Report - 2019-03-19-Investor Presentation Mithra-March€¦ · Phase III (E4 monotherapy) submission H2 2019 Indication Formulation Clinical/BioEq Filing Market Appr. Key milestones Contraception

Please pass captcha verification before submit form